You also may be interested in...
Article
7/7/2020
The Cancer Genome Atlas Project began in 2006 as a joint effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute.
Recommended Content:
Research and Innovation
Article
7/6/2020
ECMO is a heart-lung bypass system that circulates blood through an external artificial lung, oxygenates it, and delivers it back into the bloodstream.
Recommended Content:
Research and Innovation | Technology
Article
6/10/2020
15 winners of Research & Innovation Month awards announced
Recommended Content:
Research and Innovation
Article
2/14/2020
MHSRS is the Department of Defense’s premier scientific meeting
Recommended Content:
Research and Innovation
Article
11/4/2019
FedHealthIT recognized two DHA leaders, past and present, for their government service during a ceremony in Arlington, Va.
Recommended Content:
Innovation | Research and Innovation
Article
9/13/2019
Imagine unmanned vehicles bringing medical supplies or blood products to support a field medic’s care of wounded soldiers, or even transporting a wounded warfighter to safety. Researchers at the Army’s Telemedicine and Advanced Technology Research Center, or TATRC, are collaborating with the Services, academia and private industry to make such scenarios a reality.
Recommended Content:
Research and Innovation | Innovation
Article
8/20/2019
Dozens of scientists from Navy are presenting their work
Recommended Content:
Research and Innovation
Article
8/20/2019
Research, development ensures service members are better prepared, better protected, better cared for
Recommended Content:
Research and Innovation
Video
8/20/2019
Navy Medicine researchers from across the globe convened Aug. 19 in Kissimmee, Florida for the start of the 2019 Military Health System Research Symposium (MHSRS) to discuss the latest scientific advances and initiatives that support warfighter health, readiness, and survivability. We had a chance to catch up with Navy Medicine leaders to get their perspectives on the impact of research to the warfighter, the Fleet, and the Fleet Marine Force.
Recommended Content:
Research and Innovation
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity.
b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable.
c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a).
d. Supports the following objectives of the R&D EA:
(1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight.
(2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives.
(3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions.
(4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.
Showing results 16 - 30
Page 2 of 8